| Term 
 | Definition 
 
        | BRAND/GENERIC: Welchol CLASSIFICATION: Hypolipidemic, Bile Acid Sequestrant
 INDICATION: Primary hyperlipidemia
 DOSAGE FORMS: tablet; oral powder for suspension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Lipitor CLASSIFICATION: Hydroxymethlglutaryl-CoA Reductase Inhibitor
 INDICATION: Familial hypercholesterolemia; hypercholesterolemia, primary and mixed dyslipidemia, diabetes mellitus tpes 2, disorder of cardiovascular system, or multiples risk factors for coronary heart disease
 DOSAGE FORMS: tablet
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Zetia CLASSIFICATION: Antihyperlipidemic, Cholesterol Absorption Inhibitor
 INDICATION: Familial hypercholesterolemia-homozygous; mixed hyperlipidemia; primary hypercholesterolemia
 DOSAGE FORMS: oral tablet
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Vytorin CLASSIFICATION: Hydroxymethylglutarl-CoA (HMG-CoA) Reductase Inhibitor
 INDICATION: Hypercholesterolemia, primary or mixed
 DOSAGE FORMS: tablet
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Lofibra CLASSIFICATION: Antihperlipidemic
 INDICATION: hypercholesterolemia; hypertriglyceridemia, Frederick types 4 and 5 hyperlipidemia
 DOSAGE FORMS: oral tablet, oral capsule
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Lopid CLASSIFICATION: Antihyperlipidemic
 INDICATION: Coronary arteriosclerosis; prophylaxis-familila combined hyperlipidemia; familial type V hperlipoproteninemia-Fredrickson type IV hperlipoproteinemia
 DOSAGE FORMS: tablet
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Altoprev, Mevacor CLASSIFICATION: HMG-CoA Reductase Inhibitor
 INDICATION: Coronary arteriosclerosis, hypercholesterolemia, primary and mixed; familial hypercholesterolemia, heterozygous, in adolescent patients
 DOSAGE FORMS: Tablet, ER-tablet
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Niaspin, Slo-Niacin CLASSIFICATION: Antihperlipidemic
 INDICATION: Coronary arteriosclerosis, hpercholesterolemia; dyslipidemia; myocardial infarction, secondary prophylaxis; pellagra
 DOSAGE FORMS: oral capsule ER; oral tablet; oral tablet ER
 |  | 
        |  | 
        
        | Term 
 
        | OMEGA-3-ACID ETHYL ESTERS |  | Definition 
 
        | BRAND/GENERIC: Lovaza, Omacor CLASSIFICATION: Antihyperlipidemic
 INDICATION: Hypertriglyceridemia, adjunct to diet in adults with triglcerides levles 500 mg/dL or higher
 DOSAGE FORMS: Oral capsule liquid fill
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Pravachol CLASSIFICATION: HMG-CoA reductase inhibitor
 INDICATION: Cerebrovascular accident, reduction of risk; Coronary ateriosclerosis, primary and secondary prophylaxis; familial hypercholesterolemia, heterozygous; hyperlipidemia
 DOSAGE FORMS: tablet
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRAND/GENERIC: Zocor CLASSIFICATION: HMG-CoA reductase inhibitor
 INDICATION: hypercholesterolemia, primary or mixed, familial hypercholesterolemia, heterozygous; diabetes mellitus types 2, disoreder of cardiovascular systems or multiples risk factors for coronary heart disease; familial hypercholesteroelmia
 DOSAGE FORMS:
 |  | 
        |  |